Avita Medical Income Taxes 2011-2024 | RCEL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Avita Medical income taxes from 2011 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Avita Medical income taxes from 2011 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.

Related Stocks
Company Name	Market Cap
Zoetis (ZTS)	$87.5B
Takeda Pharmaceutical (TAK)	$47.5B
Merck (MKGAF)	$24.4B
Astellas Pharma (ALPMY)	$22B
Sandoz Group AG (SDZNY)	$17.6B
Summit Therapeutics (SMMT)	$16.8B
United Therapeutics (UTHR)	$15.6B
Shionogi (SGIOY)	$13.3B
Neurocrine Biosciences (NBIX)	$12.2B
Catalent (CTLT)	$10.9B
Revolution Medicines (RVMD)	$7.7B
Orion OYJ (ORINY)	$7.4B
Jazz Pharmaceuticals (JAZZ)	$6.9B
Ionis Pharmaceuticals (IONS)	$6.2B
Hikma Pharmaceuticals Plc (HKMPF)	$5.7B
Madrigal Pharmaceuticals (MDGL)	$5.3B
Crinetics Pharmaceuticals (CRNX)	$4.3B
Corcept Therapeutics (CORT)	$4.3B
Dyne Therapeutics (DYN)	$3.7B
PTC Therapeutics (PTCT)	$2.8B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.7B
Arrowhead Pharmaceuticals (ARWR)	$2.6B
Catalyst Pharmaceuticals (CPRX)	$2.5B
Soleno Therapeutics (SLNO)	$2B
Recursion Pharmaceuticals (RXRX)	$2B
Centessa Pharmaceuticals (CNTA)	$1.8B
BioCryst Pharmaceuticals (BCRX)	$1.7B
Xencor (XNCR)	$1.7B
Harrow (HROW)	$1.6B
Cassava Sciences (SAVA)	$1.5B